Takeda Pharmaceutical Co Ltd banner

Takeda Pharmaceutical Co Ltd
NYSE:TAK

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
NYSE:TAK
Watchlist
Price: 18.615 USD -0.24% Market Closed
Market Cap: $59B

Wall Street
Price Targets

TAK Price Targets Summary
Takeda Pharmaceutical Co Ltd

Wall Street analysts forecast TAK stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TAK is 17.612 USD with a low forecast of 14.995 USD and a high forecast of 21.011 USD.

Lowest
Price Target
14.995 USD
19% Downside
Average
Price Target
17.612 USD
5% Downside
Highest
Price Target
21.011 USD
13% Upside
Takeda Pharmaceutical Co Ltd Competitors:
Price Targets
LE
Lands End Inc
88% Upside

Revenue
Forecast

9% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
9% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 1%.

Operating Income
Forecast

6% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss
6% / Year
Past Growth
-5% / Year
Estimated Growth
Estimates Accuracy
-46%
Average Miss

For the last 13 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's operating income is 6%. The projected CAGR for the next 2 years is -5%.

Net Income
Forecast

-1% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
-1% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

For the last 13 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 3 years is 46%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TAK's stock price target?
Price Target
17.612 USD

According to Wall Street analysts, the average 1-year price target for TAK is 17.612 USD with a low forecast of 14.995 USD and a high forecast of 21.011 USD.

What is Takeda Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 1%.

What is Takeda Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-5%

For the last 13 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's operating income is 6%. The projected CAGR for the next 2 years is -5%.

What is Takeda Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
46%

For the last 13 years the compound annual growth rate for Takeda Pharmaceutical Co Ltd's net income is -1%. The projected CAGR for the next 3 years is 46%.

Back to Top